J. Alfaro

发表

Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities.

V. Simón, P. Solanes, M. Bono, 2013, Molecular immunology.

Rapid isothermal point-of-care test for screening of SARS-CoV-2 (COVID-19)

S. Daunert, E. Dikici, S. Deo, 2023, Aspects of Molecular Medicine.

Endoplasmic reticulum stress-independent activation of unfolded protein response kinases by a small molecule ATP-mimic

K. Shokat, P. Walter, A. Dar, 2015, eLife.

Development of Murine Lupus Involves the Combined Genetic Contribution of the SLAM and FcγR Intervals within the Nba2 Autoimmune Susceptibility Locus

L. Erickson, B. Kotzin, S. Rozzo, 2009, The Journal of Immunology.

Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies

Emma McCullagh, D. T. Hung, S. Bernales, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxia

A. Colman-Lerner, M. Blaustein, Guillermo J. Risso, 2013, PloS one.

Rapid isothermal point-of-care test for screening of SARS-CoV-2 (COVID-19)

S. Daunert, E. Dikici, S. Deo, 2023, Aspects of Molecular Medicine.

Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies

Emma McCullagh, S. Bernales, L. Delgado, 2017, The Journal of Pharmacology and Experimental Therapeutics.

JPET # 238022 1 Dual Inhibition of Bruton ’ s Tyrosine Kinase and Phosphoinositide-3-Kinase p 110 δ as a Therapeutic Approach to Treat Non-Hodgkin ’ s B cell Malignancies

Emma McCullagh, L. Delgado, R. Rai, 2017 .

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ.

Emma McCullagh, S. Bernales, Anamika Thakur, 2016, ACS medicinal chemistry letters.